ipamorelin dosing chart Ipamoralin Dosage cjc-1295 + ipamorelin dose cjc

CODEAGE Liposomal Glutathione 1000mg vi cng thc c quyn cung cp 1000mg Reduced L-Glutathione dng hot tnh c hm lng cao

Peptide Profile Compound Ipamorelin + CJC-1295 (blend) CAS Number Ipamorelin: 170851-70-4 CJC-1295: 863288-34-0 Molecular Formula Ipamorelin: CHNO CJC-1295: CHNO Molecular Weight Ipamorelin: 711.85 g/mol CJC-1295: ~3647 g/mol (structure-dependent) Sequence Ipamorelin: H-Aib-His-D-2-Nal-D-Phe-Lys-NH CJC-1295: Modified growth hormone-releasing hormone (GHRH) analogue Purity 99% (HPLC) Form Lyophilised peptide blend (solid cake) Appearance White to off-white lyophilised solid Usage & Storage Intended Use Ipamorelin and CJC-1295 are synthetic peptides supplied as a combined formulation for laboratory research applications, including biochemical and analytical studies

Ipamorelin mimics ghrelin and triggers the immediate release of growth hormone

ipamorelin's selectivity for GH release without meaningful ACTH or cortisol elevation (demonstrated in the original ipamorelin selectivity study, PMID 9849822) also means appetite is not significantly stimulated Administration method: Subcutaneous injection into abdominal fat tissue using an insulin syringe, typically administered before bedtime and at least two hours after the last meal to align with the body's natural nocturnal GH release cycle

Keep the mixed vial at 4 C and use it within 28 days